Premium
Heterozygous APOE Christchurch in familial Alzheimer’s disease without mutations in other Mendelian genes
Author(s) -
Hernandez Isabel,
Gelpi Ellen,
MolinaPorcel Laura,
Bernal Sara,
RodríguezSantiago Benjamín,
DolsIcardo Oriol,
Ruiz Agustín,
Alcolea Daniel,
Boada Mercè,
Lleó Alberto,
Clarimón Jordi
Publication year - 2021
Publication title -
neuropathology and applied neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.538
H-Index - 95
eISSN - 1365-2990
pISSN - 0305-1846
DOI - 10.1111/nan.12670
Subject(s) - mendelian inheritance , dementia , apolipoprotein e , psen1 , sibling , genetics , mutation , alzheimer's disease , disease , omim : online mendelian inheritance in man , medicine , gene , degenerative disease , biology , presenilin , pathology , psychology , phenotype , developmental psychology
We present the clinical and neuropathological findings of a patient with early onset Alzheimer's dementia (AD), heterozygous carrier of the rare Apolipoprotein E Christchurch (APOEch) variant. The patient did not harbor any pathogenic mutation in known Mendelian genes related to AD or other neurodegenerative disorders. A sibling of this patient, also carrying the APOEch variant, developed AD at the age of 66 years old. Our data suggest a possible deleterious effect of this variant, which contrast with the protective role that has been previously shown in a subject homozygous for the APOEch with he Paisa PSEN1 mutation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom